Float Short %

10.66

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

0.23

Target Price

Analyst Recom

Performance Q

-81.17

Relative Volume

Beta

0.27

Ticker: TTOO

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-01-23	TTOO	0.249	N/A	N/A	0
2025-01-24	TTOO	0.25	N/A	N/A	0
2025-01-27	TTOO	0.23	0.00	0.00	6949
2025-01-28	TTOO	0.2291	0.00	0.00	6949
2025-01-29	TTOO	0.2249	0.00	0.00	6949
2025-01-30	TTOO	0.2089	0.00	0.00	6949
2025-01-31	TTOO	0.2199	0.00	0.00	6949
2025-02-03	TTOO	0.2277	0.00	0.00	6953
2025-02-04	TTOO	0.2301	0.00	0.00	6953
2025-02-05	TTOO	0.2254	0.00	0.00	6953
2025-02-06	TTOO	0.2123	0.00	0.00	6953
2025-02-07	TTOO	0.2088	0.00	0.00	6953
2025-02-10	TTOO	0.2	0.00	0.00	6953
2025-02-11	TTOO	0.1302	N/A	N/A	0
2025-02-12	TTOO	0.0783	N/A	N/A	0
2025-02-13	TTOO	0.0695	N/A	N/A	0
2025-02-14	TTOO	0.0606	N/A	N/A	0
2025-02-18	TTOO	0.0913	N/A	N/A	0
2025-02-19	TTOO	0.229	N/A	N/A	0
2025-02-20	TTOO	0.225	N/A	N/A	0
2025-02-21	TTOO	0.18	N/A	N/A	0
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-01-23	TTOO	0.25	-	-	0.00
2025-01-24	TTOO	0.25	-	-	0.00
2025-01-27	TTOO	0.23	-	-	0.00
2025-01-28	TTOO	0.23	-	-	0.00
2025-01-29	TTOO	0.22	-	-	0.00
2025-01-30	TTOO	0.21	-	-	0.00
2025-01-31	TTOO	0.22	-	-	0.00
2025-02-03	TTOO	0.23	-	-	0.00
2025-02-04	TTOO	0.23	-	-	0.00
2025-02-05	TTOO	0.22	-	-	0.00
2025-02-06	TTOO	0.21	-	-	0.00
2025-02-07	TTOO	0.21	-	-	0.00
2025-02-10	TTOO	0.19	-	-	0.00
2025-02-11	TTOO	0.13	-	-	0.00
2025-02-12	TTOO	0.13	-	-	0.00
2025-02-13	TTOO	0.08	-	-	0.00
2025-02-14	TTOO	0.07	-	-	0.00
2025-02-18	TTOO	0.06	-	-	0.00
2025-02-19	TTOO	0.10	-	-	0.00
2025-02-20	TTOO	0.23	-	-	0.00
2025-02-21	TTOO	0.23	-	-	0.00
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-01-23	TTOO	-0.00	-11.61	7.55
2025-01-24	TTOO	-0.00	-11.61	7.55
2025-01-27	TTOO	-0.00	-8.86	7.55
2025-01-28	TTOO	-0.00	-8.86	6.63
2025-01-29	TTOO	-0.00	-8.86	6.63
2025-01-30	TTOO	-0.00	-8.86	6.63
2025-01-31	TTOO	-0.00	-8.86	6.63
2025-02-03	TTOO	-0.00	-8.04	6.63
2025-02-04	TTOO	-0.00	-8.04	6.63
2025-02-05	TTOO	-0.00	-8.04	6.63
2025-02-06	TTOO	-0.00	-8.04	6.63
2025-02-07	TTOO	-0.00	-8.04	6.63
2025-02-10	TTOO	-0.00	-8.04	6.63
2025-02-11	TTOO	-0.00	-8.04	6.63
2025-02-12	TTOO	-0.00	-8.04	6.63
2025-02-13	TTOO	-0.00	-8.04	6.63
2025-02-14	TTOO	-0.00	-8.04	6.63
2025-02-18	TTOO	-0.00	0	10.66
2025-02-19	TTOO	-0.00	0	10.66
2025-02-20	TTOO	-0.00	0	10.66
2025-02-21	TTOO	-0.00	0	10.66
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

0.27

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.9

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

0.49

P/B

P/Free Cash Flow

EPS

-0.03

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

347.6

Return on Equity vs Industry %

356.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

T2 Biosystems, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 113

T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

stock quote shares TTOO – T2 Biosystems, Inc. Stock Price stock today

news today TTOO – T2 Biosystems, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch TTOO – T2 Biosystems, Inc. yahoo finance google finance

stock history TTOO – T2 Biosystems, Inc. invest stock market

stock prices TTOO premarket after hours

ticker TTOO fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: TTOO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y